Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection

BACKGROUND AND OBJECTIVE: A limited number of studies have addressed the protective duration of coronavirus disease 2019 (COVID-19) vaccines following primary and booster doses in Saudi Arabia. Therefore, this study aimed to evaluate the protective duration of primary and booster doses of BNT162b2 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfaleh, Amjad, Alkattan, Abdullah, Alzaher, Abrar, Radwan, Nashwa, Mahmoud, Nagla, Alageel, Alaa, Alhabib, Dina, Alsalameen, Eman, Sagor, Khlood, Haji, Alhan, Alfaifi, Amal, Alabdulkareem, Khaled, Ibrahim, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425807/
https://www.ncbi.nlm.nih.gov/pubmed/36040662
http://dx.doi.org/10.1007/s40261-022-01195-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425807/
https://www.ncbi.nlm.nih.gov/pubmed/36040662
http://dx.doi.org/10.1007/s40261-022-01195-x

Ejemplares similares